Analytical Data
-
Gene name
Cr1l
- Application
-
Alternative Names
Complement regulatory protein Crry Protein p65
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q64735
-
Expression Region
41-405aa
-
Molecular Weight
44.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Cr1l (Complement Component 1, q Subcomponent, Like) is a protein that plays a significant role in the immune response and has been linked to various physiological processes, including inflammation and tissue repair. Research into Cr1l has gained momentum due to its potential implications in understanding certain diseases, such as autoimmune disorders and infections. The protein is part of the complement system, which is crucial for pathogen clearance and the regulation of inflammatory responses. Advances in molecular biology techniques have enabled scientists to investigate Cr1l's structure, function, and interaction with other immune components at a more detailed level. Furthermore, studies have shown that Cr1l expression can be modulated by various stimuli, suggesting its dynamic role in pathophysiological conditions. The intricate balance of Cr1l's function poses interesting questions regarding its therapeutic potential, as targeting this protein could provide new avenues for treatment strategies in diseases characterized by immune dysregulation. Understanding the mechanisms by which Cr1l operates could lead to further insights into its role in health and disease, making it a compelling focus for ongoing research in immunology and molecular medicine.
